Navigation Links
Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform
Date:10/30/2008

Improved laboratory efficiencies and standardization to personalize patient

care

PLEASANTON, Calif., Oct. 30 /PRNewswire/ -- Roche Molecular Diagnostics today announced that the U.S. Food & Drug Administration (FDA) has approved the COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HCV Test for use in the United States. The test uses Roche's proprietary real-time PCR technology to quantify the amount of Hepatitis C RNA in a patient's blood. Physicians use Hepatitis C viral load testing results to establish a baseline level of hepatitis C infection and to serially monitor viral load levels and treatment effectiveness in patients on therapy.

"This new Roche test enables laboratories to deliver reliable healthcare information with ease and allows physicians to more efficiently monitor their patients and improve treatment outcomes," said Daniel O'Day, President and CEO of Roche Molecular Diagnostics. "We are pleased to offer this new solution for laboratories and physicians to optimize their turnaround time, workflow and patient care with simultaneous processing of HIV and HCV patient samples."

The new test offers a broad dynamic range from high levels of virus in a patients blood to the "undetectable" low levels of viremia -- the goal of therapy. To ensure accurate quantification, the test has been calibrated to World Health Organization (WHO) traceable standards and can detect down to 18 IU/mL with 100% certainty. In a 1,281 patient clinical trial, the COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HCV Test confirmed the importance of viral load testing to personalize Hepatitis C patient care by accurately predicting treatment response, from onset of therapy through end of treatment.

About the COBAS(R) AmpliPrep/COBAS(R) TaqMan(R) System

The COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HCV Viral Load Test is designed for use on the first fully automated, FDA approved, real-time PCR platform, providing sample-in/res
'/>"/>

SOURCE Roche Molecular Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
2. Genentech/Roche/Chugais Avastin Will Garner More Than 20 Percent of the Total Breast Cancer Drug Market in 2017
3. Balloon Manor Reappears in Rochester
4. Safety Threat to Rochester Still Remains Despite Approval Of Canadian Pacifics Railroad Acquisition Of DM&E
5. Rochester Medical Implants Achieves ISO 13485:2003 Certification for Medical Device Manufacturing
6. Autovan Donates Wheelchair-Accessible Van; Brings Greater Mobility to Facility in Rochester, New York
7. Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugais Actemra for Rheumatoid Arthritis
8. Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
9. New Roche Chlamydia Test Approved for Use in European Union
10. Rochester Medical Honored by Premier Healthcare Alliance for Exceeding Performance Expectations
11. Rochester Coalition and Mayo Clinic Challenge Railroads Contention That Hazmat Rail Shipments Pose no Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... NV (PRWEB) , ... September 02, 2015 , ... ... and Fort Lauderdale, CENTURION SERVICE GROUP is internationally known as an industry leader ... auction house in the world, selling more than 100,000 pieces of medical equipment ...
(Date:9/2/2015)... ... September 02, 2015 , ... “ G-Hold ” was featured on ... technology products available to consumers. Amanda Forstrom, a technology expert and special reporter for ... people to comfortably hold a tablet while reducing the likelihood of it dropping. , ...
(Date:9/2/2015)... ... September 02, 2015 , ... Canopy Partners, ... named to the Inc. 5000 List, an independent ranking of the fastest- ... 34 years, and this achievement puts Canopy in rarefied company. Over the years, ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... for the telling the truth about medicine and health, truths that other doctors ... blog, where he plans to regularly debunk certain misconceptions surrounding cholesterol, metabolically directed ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... (FDA) for the treatment of androgenic alopecia in adults, announces Miami-based medical device ... therapy cap, while also demonstrating its safety when used at home to combat ...
Breaking Medicine News(10 mins):Health News:Over 1800 Lots of Surplus Used Medical Equipment 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 3Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2
... ... ... ... ...
... ... ... ... ...
... ... ... , ... , , , ...
... in the March edition of the Journal of ... patient,s outlook as it relates to health behavior and ... discovered that those who exhibited an optimistic disposition experienced ... Previous research into how the body communicates ...
... for advanced endoscopic procedures with a low rate of ... according to a new study in Clinical Gastroenterology ... Gastroenterological Association (AGA) Institute. "This is the ... (AMs) associated with propofol use in endoscopy. We believe ...
... ... objective of the PACT program is to continue to advance cellular ... and biologic systems, and targeted treatments for serious diseases without effective ... research in novel cell therapies, to advance the field of cellular ...
Cached Medicine News:Health News:The First Annual CQ HealthBeat Conference 2Health News:The First Annual CQ HealthBeat Conference 3Health News:The First Annual CQ HealthBeat Conference 4Health News:The First Annual CQ HealthBeat Conference 5Health News:Battling a Biceps Injury 2Health News:Battling a Biceps Injury 3Health News:Battling a Biceps Injury 4Health News:Battling a Biceps Injury 5Health News:Battling a Biceps Injury 6Health News:Battling a Biceps Injury 7Health News:AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 2Health News:AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 3Health News:Lung cancer research explores the effects of patient attitudes on patient outcomes 2Health News:Adverse events rate is low when propofol is administered by trained professional 2Health News:NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT) 2Health News:NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT) 3
(Date:9/1/2015)... , Sept. 1, 2015   Ivenix Inc. ... infusion management system, closed on a $42M round ... Healthcare Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, ... in the round. This financing will support the ... market. Leerink Partners LLC acted as the exclusive ...
(Date:9/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ... in oncology, today announced that Steven A. ... David Haen , Vice President of Business ... overview at two significant investment conferences in September, ... the FBR & Co. Second Annual Health Conference ...
(Date:9/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/r8v22b/regulatory ) has announced the ... (London, UK - September 24-25, 2015)" conference to ... provides an introduction to Pharmaceutical Regulatory Affairs and the ... for those working in a support staff role. ... regulatory procedures required to register products in ...
Breaking Medicine Technology:Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4Regulatory Affairs for Support Staff Seminar (London, UK - September 24-25, 2015) 2
... 2011 Gen-Probe Incorporated (Nasdaq: GPRO ) announced today ... RBC Capital Markets, Healthcare Conference in New York at 10 ... participate in a panel discussion entitled The Future of Molecular ... and Company,s 31st Annual Healthcare Conference in Boston at 10:15 a.m. ...
... Calif., Feb. 24, 2011 Amgen (Nasdaq: ... Healthcare Conference on Tuesday, March 1, 2011, at the ... at 11:30 a.m. Eastern Time. Rolf Hoffmann, senior vice ... Investor Relations will present at the conference.  Live audio ...
Cached Medicine Technology:Gen-Probe to Webcast Three Upcoming Investor Presentations 2
... One device provides both low ... a single gas source , Reduce ... number of SKUs dedicated to nebulizers ... of double or wye set ups ...
... achieves optimum lung penetration for maximum therapeutic ... 1.04-1.10 µ at 6-8 LPM. Latex-free components. ... ,As the world leader in airway management ... of proven technology by offering top brands ...
... is improved CNBT technology, which relieves the practitioner ... 15 minutes. HOPE allows you the ability to ... administration couldn't be easier, with a length of ... can turn the HOPE nebulizer into an inexpensive ...
... Thera-Mist® Air Entrainment Nebulizers deliver particulate humidity ... for your chronic secretion patients. For your ... your existing supply of sterile water., ... at FiO2's of 20-50% with a total ...
Medicine Products: